D-4418, is PDE4 inhibitors has been in development as a novel anti-inflammatory therapy with asthma and chronic obstructive pulmonary disease (COPD) being primary indications. References: Crocker IC, Townley RG. Therapeutic potential of phosphodiesterase 4 inhibitors in allergic diseases. Drugs Today (Barc). 1999 Jul;35(7):519-35. PubMed PMID: 12973397.

纯度：≥98%

CAS：257892-34-5